Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology

What results can I expect from orthostatic tremor treatment?

At a Glance

For primary orthostatic tremor, treatment usually provides partial symptom relief rather than a cure. The most useful measure of success is safer, longer standing and better daily function, balanced against medication side effects and fall risk.

Treatment for confirmed primary orthostatic tremor (POT) rarely results in a complete cure. The realistic goal is to improve your quality of life, increase your confidence, and expand your ability to participate in daily activities safely. Evidence for POT treatments is limited and based mostly on small observational studies rather than large clinical trials [1]. Because of this, therapies often offer partial relief rather than total tremor suppression, and finding the right approach requires patience and trial and error under a doctor’s supervision [2].

Defining Success: Function Over Cure

Since eliminating the tremor entirely is uncommon, it helps to focus on functional goals. Success is measured by how treatment improves your ability to engage in life. When evaluating a treatment, look for improvements in:

  • Longer standing time: Can you stand unsupported for a bit longer without needing to sit, walk, or lean?
  • Safer transfers and mobility: Do you feel more stable getting out of a chair, or more confident when walking?
  • Fewer near-falls: Is your fear of falling reduced, and are you feeling less off-balance?
  • Daily activities: Are you better able to manage tasks like showering, cooking, or waiting in line? One study of a Swedish POT cohort found that, despite significant symptoms, 65% of patients maintained independence in activities of daily living [3]. However, “independence” does not mean a lack of struggle—many patients still rely on aids, strategic leaning, or caregiver support to navigate their day [4].

The Reality of Medication Responses and Safety

Medications for POT affect everyone differently. Because evidence relies heavily on small or retrospective studies, predicting any individual’s response is difficult [5].

  • Benzodiazepines (a class of sedative medications, such as clonazepam): In a retrospective study of 184 POT patients, medications in this class provided mild benefit for about 56% of patients and moderate-to-marked benefit for roughly 31% [6].
  • Gabapentin (a nerve pain and anti-seizure medication): Systematic reviews identify gabapentin as having some of the most robust data among available studies, but individual responses still vary widely [5].

Important Safety Warnings: You must weigh the relief of your tremor against potential side effects. Both clonazepam and gabapentin can cause drowsiness, dizziness, confusion, or unsteadiness, which can paradoxically increase your risk of falls [1][7]. Gabapentin also requires monitoring of kidney function. Crucially:

  • Never start, stop, or change doses without your prescriber’s guidance.
  • Do not stop clonazepam abruptly, as withdrawal can be dangerous and cause a severe rebound in symptoms [8].
  • Avoid mixing these medications with alcohol, opioids, or other sedatives, which dangerously increases sedation and fall risk [7].

Symptom Relief vs. Disease Modification

Current treatments offer symptom relief—they help manage how you feel and function while they are active in your system. However, there is no proven disease-modifying treatment (a therapy that can cure the underlying disease or definitively stop it from progressing) [2][1]. The natural course of POT is variable; while some people experience a slow worsening of symptoms over years, this is not identical for everyone, and the condition’s progression is incompletely studied [9][10]. If a medication seems to become less effective over time, it may be due to disease progression, medication tolerance, or natural variability, and you should discuss adjusting your strategy with your doctor [6].

Non-Drug Support and Physical Therapy

Because medications only go so far, non-drug strategies are vital. A physical or occupational therapist familiar with movement disorders can help you maintain independence by:

  • Assessing and fitting you for walking aids, such as a specialized walker or cane.
  • Teaching safe strategies for leaning or weight-shifting to manage symptoms during daily tasks.
  • Recommending home adaptations, such as grab bars, shower chairs, or seated cooking setups, to conserve your energy and reduce the burden of standing [4].

Advanced Options: Deep Brain Stimulation

For rare cases where symptoms are profoundly disabling and do not respond to medication (a state called medication-refractory), deep brain stimulation (DBS) may be considered [11]. DBS is an invasive brain surgery where electrodes are implanted to regulate abnormal brain signals. Small studies suggest DBS can significantly increase standing time for carefully selected patients [12]. However, this is not a guaranteed fix. It requires evaluation at a specialized center and carries major risks, including bleeding, stroke, infection, speech or cognitive changes, balance issues, and the need for ongoing device programming [11][13].

Tracking Your Baseline Safely

The best way to know if a therapy is working is to safely track your own data. Before starting a treatment, record your baseline standing time and function. When testing your standing time, do it safely: test only in a controlled setting near a sturdy counter or with another person present, and stop at the first sign of unsafe unsteadiness—do not push yourself until you feel you might fall.

Keep a simple log that tracks:

  • Medication timing: When you took your dose.
  • Standing tolerance: How long you can safely stand (and whether you used an aid).
  • Daily tasks: Your ability to complete a priority activity.
  • Safety incidents: Any falls or near-falls.
  • Side effects: Fatigue, brain fog, or dizziness.

You might also ask your doctor about the Orthostatic Tremor Severity and Disability Scale—a validated questionnaire that helps measure how your symptoms impact your daily life over the past week [14]. By bringing this concrete data to your appointments, you and your care team can make informed decisions about your treatment plan.

Common questions in this guide

What is a realistic treatment goal for primary orthostatic tremor?
A realistic goal is often to stand longer, transfer and walk more safely, reduce near-falls, and complete more daily activities. Complete elimination of the tremor is uncommon, so improvement in function and quality of life is usually more useful than aiming for a cure.
How much relief can clonazepam or gabapentin provide for orthostatic tremor?
Medication response varies from person to person. In a retrospective study of 184 people with primary orthostatic tremor, benzodiazepines such as clonazepam provided mild benefit for about 56% and moderate-to-marked benefit for about 31%; gabapentin has relatively strong evidence compared with other options, but it does not work equally well for everyone.
Can treatment cure primary orthostatic tremor or stop it from progressing?
Current treatments provide symptom relief, but no proven treatment cures the underlying condition or definitively prevents progression. The course varies: symptoms may slowly worsen for some people but not others, and reduced medication benefit may reflect progression, medication tolerance, or natural variability.
What medication safety issues should I know about?
Clonazepam and gabapentin can cause drowsiness, dizziness, confusion, or unsteadiness, which may increase fall risk. Gabapentin may require kidney-function monitoring, and these medicines should not be mixed with alcohol, opioids, or other sedatives. Never change a dose without your prescriber's guidance, and do not stop clonazepam abruptly.
Could physical or occupational therapy help if medication is not enough?
A therapist familiar with movement disorders can help select a walking aid, teach safe leaning or weight-shifting strategies, and recommend adaptations such as grab bars, a shower chair, or seated cooking. These measures can reduce the burden of standing and support independence, although they do not eliminate the tremor.
When might deep brain stimulation be considered for orthostatic tremor?
Deep brain stimulation may be considered only in rare cases with profound disability and inadequate response to medication. It requires evaluation at a specialized center and may increase standing time in selected patients, but it is invasive and carries risks such as bleeding, stroke, infection, speech or cognitive changes, balance problems, and the need for ongoing programming.
How can I tell whether an orthostatic tremor treatment is actually helping?
Track your medication timing, safely measured standing tolerance, ability to complete priority activities, falls or near-falls, and side effects such as fatigue or dizziness. Measure standing only in a controlled setting near support or with another person present, stop before you become unsafe, and consider asking your clinician about the Orthostatic Tremor Severity and Disability Scale.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Primary orthostatic tremor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my current baseline standing time, what specific increase in standing tolerance would you consider a successful response to this medication?
  2. 2.How will we monitor whether the potential side effects of this medication, such as dizziness or drowsiness, are outweighing the benefits for my balance and fall risk?
  3. 3.Can you refer me to a physical or occupational therapist who has experience with movement disorders to help me with fall prevention and assistive devices?
  4. 4.If this medication provides only partial relief or loses its effectiveness over time, what is our timeline for adjusting the dose or trying a different strategy?

References

References (14)
  1. 1

    How to treat orthostatic tremor - Cohort study and systematic review.

    Babeliowsky WA, Meulepas MA, Buijink AWG, et al.

    Clinical parkinsonism & related disorders 2025; (12()):100318 doi:10.1016/j.prdoa.2025.100318.

    PMID: 40256684
  2. 2

    Orthostatic Tremor: Pathophysiology Guiding Treatment.

    Whitney D, Bhatti D, Torres-Russotto D

    Current treatment options in neurology 2018; (20(9)):35 doi:10.1007/s11940-018-0524-3.

    PMID: 30032366
  3. 3

    Clinical Characteristics of Primary Orthostatic Tremor - a Comprehensive Clinical Assessment of Patients in Sweden.

    Af Edholm K, Sundgren M, Fransén E, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2026; (16()):14 doi:10.5334/tohm.1143.

    PMID: 41798182
  4. 4

    Lessons I have learned from my patients: everyday life with primary orthostatic tremor.

    Vidailhet M, Roze E, Maugest L, Gallea C

    Journal of clinical movement disorders 2017; (4()):1 doi:10.1186/s40734-016-0048-5.

    PMID: 28101372
  5. 5

    Systematic review of pharmacological treatment options for orthostatic tremor in prospective patient cohorts and randomized controlled trials.

    Sauthoff L, Achutegui MI, Ye L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(8)):3419-3425 doi:10.1007/s10072-025-08129-3.

    PMID: 40155580
  6. 6

    Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

    Hassan A, Ahlskog JE, Matsumoto JY, et al.

    Neurology 2016; (86(5)):458-64 doi:10.1212/WNL.0000000000002328.

    PMID: 26747880
  7. 7

    Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.

    Tóth K, Csukly G, Sirok D, et al.

    The international journal of neuropsychopharmacology 2016; (19(12)) doi:10.1093/ijnp/pyw083.

    PMID: 27639091
  8. 8

    Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use.

    Dokkedal-Silva V, Berro LF, Galduróz JCF, et al.

    Harvard review of psychiatry 2019; (27(5)):279-289 doi:10.1097/HRP.0000000000000227.

    PMID: 31385811
  9. 9

    The long-term outcome of orthostatic tremor.

    Ganos C, Maugest L, Apartis E, et al.

    Journal of neurology, neurosurgery, and psychiatry 2016; (87(2)):167-72 doi:10.1136/jnnp-2014-309942.

    PMID: 25770124
  10. 10

    Long-term course of orthostatic tremor in serial posturographic measurement.

    Feil K, Böttcher N, Guri F, et al.

    Parkinsonism & related disorders 2015; (21(8)):905-10.

    PMID: 26071126
  11. 11

    Deep brain stimulation and spinal cord stimulation for orthostatic tremor: A systematic review.

    Boogers A, Billet A, Vandenberghe W, et al.

    Parkinsonism & related disorders 2022; (104()):115-120 doi:10.1016/j.parkreldis.2022.10.001.

    PMID: 36243552
  12. 12

    Deep brain stimulation for orthostatic tremor: A single-center case series.

    Hewitt AL, Klassen BT, Lee KH, et al.

    Neurology. Clinical practice 2020; (10(4)):324-332 doi:10.1212/CPJ.0000000000000730.

    PMID: 32983612
  13. 13

    Deep Brain Stimulation for Orthostatic Tremor: An Observational Study.

    Babeliowsky WA, Bot M, Potters WV, et al.

    Movement disorders clinical practice 2024; (11(6)):676-685 doi:10.1002/mdc3.14035.

    PMID: 38586984
  14. 14

    Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10).

    Merola A, Torres-Russotto DR, Stebbins GT, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(10)):1796-1801 doi:10.1002/mds.28142.

    PMID: 32562441

This page is for informational purposes only and does not constitute medical advice. Because medication side effects, fall risk, and treatment response vary, discuss any medication change, therapy referral, or deep brain stimulation evaluation with your treating clinician.